Literature DB >> 24035996

PAQR3 has modulatory roles in obesity, energy metabolism, and leptin signaling.

Lingdi Wang1, Xiao Wang, Zhenghu Li, Tingting Xia, Lu Zhu, Bin Liu, Yongxian Zhang, Fei Xiao, Yi Pan, Yong Liu, Feifan Guo, Yan Chen.   

Abstract

Diet-induced obesity is commonly associated with leptin resistance, and attenuated leptin signaling contributes to the progression of obesity. PAQR3 is a member of the progesterone and AdipoQ receptor (PAQR) family with close homology to adiponectin receptors. We hypothesized that PAQR3 is implicated in the regulation of obesity and energy homeostasis. To address this hypothesis, we fed Paqr3-deleted mice with high-fat diet (HFD), followed by analyses to evaluate obesity, hepatic steatosis, insulin resistance, metabolic rate, and leptin signaling. We found that mice with deletion of Paqr3 are resistant to HFD-induced obesity and hepatic steatosis, accompanied by improvement of insulin resistance and insulin signaling. Paqr3-deleted mice have an increased energy expenditure and physical activity. HFD-induced leptin resistance is reversed by Paqr3 ablation. Overexpression of PAQR3 reduces leptin signaling whereas deletion of Paqr3 enhances leptin signaling in the hypothalamus. In conclusion, this study reveals that PAQR3 has an important physiological function in modulating obesity, energy metabolism, and leptin signaling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24035996     DOI: 10.1210/en.2013-1633

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

Review 1.  Role of the Golgi Apparatus in the Blood-Brain Barrier: Golgi Protection May Be a Targeted Therapy for Neurological Diseases.

Authors:  Shuwen Deng; Hui Liu; Ke Qiu; Hong You; Qiang Lei; Wei Lu
Journal:  Mol Neurobiol       Date:  2017-07-20       Impact factor: 5.590

Review 2.  Characterization of Golgi scaffold proteins and their roles in compartmentalizing cell signaling.

Authors:  Wenna Peng; Qiang Lei; Zheng Jiang; Zhiping Hu
Journal:  J Mol Histol       Date:  2013-12-14       Impact factor: 2.611

3.  MicroRNA-543 acts as an oncogene by targeting PAQR3 in hepatocellular carcinoma.

Authors:  Lei Yu; Luting Zhou; Yu Cheng; Lei Sun; Jian Fan; Jinlong Liang; Mujie Guo; Ning Liu; Liying Zhu
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

4.  The tumor suppressor role of PAQR3 in osteosarcoma.

Authors:  Zhiqiang Ma; Yanlong Wang; Taikui Piao; Zhaopeng Li; Hongyu Zhang; Zhixin Liu; Jianyu Liu
Journal:  Tumour Biol       Date:  2014-12-17

5.  PAQR3 plays a suppressive role in laryngeal squamous cell carcinoma.

Authors:  Qiang Wu; Kun Zhuang; Huijun Li
Journal:  Tumour Biol       Date:  2015-08-01

Review 6.  PAQR3: a novel tumor suppressor gene.

Authors:  Xin Yu; Zheng Li; Matthew Tv Chan; William Ka Kei Wu
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

7.  PAQR3 expression is downregulated in human breast cancers and correlated with HER2 expression.

Authors:  Zhenghu Li; Zhi-Qiang Ling; Weiwei Guo; Xiao-Xiao Lu; Yi Pan; Zhenzhen Wang; Yan Chen
Journal:  Oncotarget       Date:  2015-05-20

8.  PAQR3 modulates cholesterol homeostasis by anchoring Scap/SREBP complex to the Golgi apparatus.

Authors:  Daqian Xu; Zheng Wang; Yuxue Zhang; Wei Jiang; Yi Pan; Bao-Liang Song; Yan Chen
Journal:  Nat Commun       Date:  2015-08-27       Impact factor: 14.919

9.  MicroRNA-137 upregulation increases bladder cancer cell proliferation and invasion by targeting PAQR3.

Authors:  Youcheng Xiu; Zan Liu; Shunyao Xia; Chengjun Jin; Huaifu Yin; Weiming Zhao; Qiong Wu
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

10.  Effect of Tetramethylpyrazine on Atherosclerosis and SCAP/SREBP-1c Signaling Pathway in ApoE-/- Mice Fed with a High-Fat Diet.

Authors:  Ying Zhang; Pan Ren; Qunfu Kang; Weihong Liu; Sinai Li; Ping Li; Hongxu Liu; Juju Shang; Lei Zhang; Yanbing Gong; Mingxue Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2017-04-12       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.